Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 05/30/2025 | 136,973,697 | Total gross of voting rights: 136,973,697 |
Total net* of voting rights: 136,738,528 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$9.07 |
| Daily Change: | 0.52 6.02 |
| Daily Volume: | 41,023 |
| Market Cap: | US$186.010M |
January 08, 2025 December 11, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
